Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market

January 1999

You're going to hear a lot about Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market.

It'll be co-promoted by Searle and Pfizer.

Celebrex is approved for osteo- and rheumatoid arthritis. It's as effective as other NSAIDs for joint pain and swelling.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Celebrex (celecoxib), the first COX-2 selective NSAID to hit the market
Cardiology another angiotensin II receptor blocker called Micardis (telmisartan)
Anticoagulants new recommendations to prevent MIs
Anticoagulants ORAL vitamin K (phytonadione, Mephyton) is now recommended to reverse warfarin's anticoagulant effects
Cardiology Norvasc REDUCES cardiovascular morbidity and mortality in patients with coronary artery disease
Infectious Diseases Lymerix, the first vaccine on the market to prevent Lyme disease
Infectious Diseases whether antibiotics are really necessary before dental procedures to prevent endocarditis
vitamin E reduces the severity of tardive dyskinesia
People taking benzodiazepines seem to have more than DOUBLE the risk of traffic accidents
Is echinacea useful for colds?
Glaucoma more emphasis on glaucoma testing and treatment
Glaucoma Five different drug classes are now available for glaucoma
Gastroenterology new guidelines to prevent and treat ulcers caused by NSAIDs
Neurology & Pain Neurontin (gabapentin) for pain
Neurology & Pain new fentanyl lozenge called Actiq
Women's Health Prometrium (micronized progesterone) is now approved for hormone replacement therapy (HRT)
Practice new report on NON-herbal dietary supplements